StonvexLoading…
StonvexStonvexStonvexCore line items from UMH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $69.62M | $6.37M | $35.04M | $26.28M | $17.13M |
Operating Income | Not available | Not available | Not available | Not available | Not available |
Net Income | Not available | $7.69M | $26.27M | $21.70M | $7.61M |
EPS (Diluted) | $0.03 | $0.03 | $0.07 | $0.08 | $0.03 |
Total Assets | Not available | $1.69B | $1.70B | $1.63B | $1.62B |
Total Liabilities | Not available | $791.58M | $791.84M | $703.12M | $690.26M |
Cash & Equivalents | Not available | $37.41M | $72.10M | $34.06M | $79.23M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 85.14M | 84.85M | 85.20M | 84.74M |